T1	Observation 36 41	msSBP
E1	Observation:T1 Name:T2 Eq-Comparison:E2 Eq-Comparison2:E3
T2	Observation-Name 36 41	msSBP
A1	Observation-Type-Value T2 vital
T3	Eq-Comparison 25 35	145 mmHg ≤
E2	Eq-Comparison:T3 Value:T4 Unit:T5 Operator:T6
T4	Eq-Value 25 28	145
T5	Eq-Unit 29 33	mmHg
T6	Eq-Operator 34 35	≤
A2	Eq-Operator-Value T6 LTEQ
T7	Eq-Comparison 42 52	≤ 190 mmHg
E3	Eq-Comparison:T7 Operator:T8 Value:T9 Unit:T10
T8	Eq-Operator 42 43	≤
A3	Eq-Operator-Value T8 LTEQ
T9	Eq-Value 44 47	190
T10	Eq-Unit 48 52	mmHg
T11	Observation 58 71	Triglycerides
E4	Observation:T11 Name:T12 Eq-Comparison:E5
T12	Observation-Name 58 71	Triglycerides
A4	Observation-Type-Value T12 lab
T13	Eq-Comparison 72 83	< 500 mg/dL
E5	Eq-Comparison:T13 Operator:T14 Value:T15 Unit:T16 Per:T17
T14	Eq-Operator 72 73	<
A5	Eq-Operator-Value T14 LT
T15	Eq-Value 74 77	500
T16	Eq-Unit 78 80	mg
T17	Eq-Unit 81 83	dL
T18	Observation 89 94	LDL-C
E6	Observation:T18 Name:T19
T19	Observation-Name 89 94	LDL-C
A6	Observation-Type-Value T19 lab
T20	Eq-Comparison 95 106	≤ 250 mg/dL
E7	Eq-Comparison:T20 Operator:T21 Value:T22 Unit:T23 Per:T24
T21	Eq-Operator 95 96	≤
A7	Eq-Operator-Value T21 LTEQ
T22	Eq-Value 97 100	250
T23	Eq-Unit 101 103	mg
T24	Eq-Unit 104 106	dL
T25	Observation 132 136	sSBP
E8	Observation:T25 Name:T26 Eq-Comparison:E9
T26	Observation-Name 132 136	sSBP
A8	Observation-Type-Value T26 vital
T27	Eq-Comparison 137 145	≥ 20mmHg
E9	Eq-Comparison:T27 Operator:T28 Value:T29 Unit:T30
T28	Eq-Operator 137 138	≥
A9	Eq-Operator-Value T28 GTEQ
T29	Eq-Value 139 141	20
T30	Eq-Unit 141 145	mmHg
T31	Observation 150 154	sDBP
E10	Observation:T31 Name:T32 Eq-Comparison:E11
T32	Observation-Name 150 154	sDBP
A10	Observation-Type-Value T32 vital
T33	Eq-Comparison 155 163	≥ 10mmHg
E11	Eq-Comparison:T33 Operator:T34 Value:T35 Temporal-Unit:T36
T34	Eq-Operator 155 156	≥
A11	Eq-Operator-Value T34 GTEQ
T35	Eq-Value 157 159	10
T36	Eq-Temporal-Unit 159 163	mmHg
T37	And 146 149	and
E12	And:T37 Arg:E8 Arg2:E10
T38	Assertion 169 180	symptomatic
E13	Assertion:T38 Asserted:E15
A12	Assertion-Type-Value E13 possible
T39	Modifier 181 192	orthostatic
E14	Modifier:T39 Modifies:T41
T40	Condition 193 204	hypotension
E15	Condition:T40 Name:T41
T41	Condition-Name 193 204	hypotension
T42	Condition 230 242	hypertension
E16	Condition:T42 Name:T43
T43	Condition-Name 230 242	hypertension
T44	Condition 247 259	dyslipidemia
E17	Condition:T44 Name:T45
T45	Condition-Name 247 259	dyslipidemia
T46	Or 243 246	and
E18	Or:T46 Arg:E16 Arg2:E17
T47	Modifier 219 229	iatrogenic
E19	Modifier:T47 Modifies:T43
T48	Modifier 209 218	secondary
E20	Modifier:T48 Modifies:T43
T49	Or 218 219	/
E21	Or:T49 Arg:E20 Arg2:E19
T50	Or 205 208	and
E22	Or:T50 Arg:E15 Arg2:E16
T51	Eq-Comparison 265 272	history
E23	Eq-Comparison:T51 Temporal-Period:T52
T52	Eq-Temporal-Period 265 272	history
A13	Eq-Temporal-Period-Value T52 past
T53	Condition 295 312	cerebral ischemia
E24	Condition:T53 Name:T54 Severity:T57 Temporality:E23
T54	Condition-Name 295 312	cerebral ischemia
T55	Eq-Comparison 276 294	moderate to severe
E25	Eq-Comparison:T55 Value:T56 Operator:T58 Value2:T57
T56	Severity 276 284	moderate
A14	Severity-Value T56 moderate
T57	Severity 288 294	severe
A15	Severity-Value T57 severe
T58	Eq-Operator 285 287	to
A16	Eq-Operator-Value T58 BETWEEN
T59	Condition 314 333	cerebral hemorrhage
E26	Condition:T59 Name:T60
T60	Condition-Name 314 333	cerebral hemorrhage
T61	Condition 335 360	transient ischemic attack
E27	Condition:T61 Name:T62
T62	Condition-Name 335 360	transient ischemic attack
T63	Condition 362 383	myocardial infarction
E28	Condition:T63 Name:T64
T64	Condition-Name 362 383	myocardial infarction
T65	Condition 397 403	angina
E29	Condition:T65 Name:T66 Stability:T67 Temporality:E31
T66	Condition-Name 397 403	angina
T67	Stability 388 396	unstable
A17	Stability-Value T67 change
T68	Or 385 387	or
E30	Or:T68 Arg:E28 Arg2:E29
T69	Eq-Comparison 411 424	past 6 months
E31	Eq-Comparison:T69 Temporal-Period:T70 Value:T71 Temporal-Unit:T72
T70	Eq-Temporal-Period 411 415	past
A18	Eq-Temporal-Period-Value T70 past
T71	Eq-Value 416 417	6
T72	Eq-Temporal-Unit 418 424	months
A19	Eq-Temporal-Unit-Value T72 month
T73	Condition 433 446	heart failure
E32	Condition:T73 Name:T74 Severity:T75
T74	Condition-Name 433 446	heart failure
T75	Severity 426 432	severe
A20	Severity-Value T75 severe
T76	Condition 448 474	New York Heart Association
E33	Condition:T76 Name:T77 Stage:E34
T77	Condition-Name 448 474	New York Heart Association
T78	Eq-Comparison 486 502	class III and IV
E34	Eq-Comparison:T78 Value:T79 Value2:T80 Unit:T81
T79	Eq-Value 492 495	III
T80	Eq-Value 500 502	IV
T81	Eq-Unit 486 491	class
R1	Equivalent-To Arg1:E33 Arg2:E32	
T82	Condition 509 525	hypersensitivity
E35	Condition:T82 Name:T83
T83	Condition-Name 509 525	hypersensitivity
T84	Drug 529 540	telmisartan
E36	Drug:T84 Name:T85
T85	Drug-Name 529 540	telmisartan
T86	Drug-Name 544 556	rosuvastatin
T87	Drug 544 556	rosuvastatin
E37	Drug:T87 Name:T86
R2	Caused-By Arg1:E35 Arg2:E36	
R3	Caused-By Arg1:E35 Arg2:E37	
T88	Or 541 543	or
E38	Or:T88 Arg:E36 Arg2:E37
T89	Eq-Comparison 562 569	history
E39	Eq-Comparison:T89 Temporal-Period:T90
T90	Eq-Temporal-Period 562 569	history
A21	Eq-Temporal-Period-Value T90 past
T91	Condition 573 583	angioedema
E40	Condition:T91 Name:T92 Temporality:E39
T92	Condition-Name 573 583	angioedema
T93	Procedure 590 599	treatment
E41	Procedure:T93 
T94	Temporal-Connection 584 589	after
E42	Temporal-Connection:T94 Arg:E40 Arg2:E41
A22	Temporal-Connection-Type-Value E42 after
T95	Drug 605 645	angiotensin-converting enzyme inhibitors
E43	Drug:T95 Name:T96
T96	Drug-Name 605 645	angiotensin-converting enzyme inhibitors
T97	Drug 649 653	ARBs
E44	Drug:T97 Name:T98
T98	Drug-Name 649 653	ARBs
R4	Using Arg1:E41 Arg2:E43	
T99	Or 646 648	or
E45	Or:T99 Arg:E43 Arg2:E44
T100	Observation 655 679	creatinine phosphokinase
E46	Observation:T100 Name:T101 Eq-Comparison:E47
T101	Observation-Name 655 679	creatinine phosphokinase
A23	Observation-Type-Value T101 lab
T102	Eq-Comparison 687 721	≥3 times the upper limit of normal
E47	Eq-Comparison:T102 Operator:T103 Value:T104 Unit:T105
T103	Eq-Operator 687 688	≥
A24	Eq-Operator-Value T103 GTEQ
T104	Eq-Value 688 689	3
T105	Eq-Unit 700 721	upper limit of normal
A25	Eq-Unit-Value T105 ref-range-normal
T106	Observation 727 763	estimated glomerular filtration rate
E48	Observation:T106 Name:T107 Eq-Comparison:E49
T107	Observation-Name 727 763	estimated glomerular filtration rate
A26	Observation-Type-Value T107 lab
T108	Eq-Comparison 764 774	≤30 mL/min
E49	Eq-Comparison:T108 Operator:T109 Value:T110 Unit:T111 Per:T112
T109	Eq-Operator 764 765	≤
A27	Eq-Operator-Value T109 LTEQ
T110	Eq-Value 765 767	30
T111	Eq-Unit 768 770	mL
T112	Eq-Temporal-Unit 771 774	min
A28	Eq-Temporal-Unit-Value T112 minute
T113	Observation 776 802	aspartate aminotransferase
E50	Observation:T113 Name:T114
T114	Observation-Name 776 802	aspartate aminotransferase
A29	Observation-Type-Value T114 lab
T115	Observation 807 831	alanine aminotransferase
E51	Observation:T115 Name:T116
T116	Observation-Name 807 831	alanine aminotransferase
A30	Observation-Type-Value T116 lab
T117	Or 803 806	and
E52	Or:T117 Arg:E50 Arg2:E51
T118	Eq-Comparison 839 873	≥3 times the upper limit of normal
E53	Eq-Comparison:T118 Operator:T119 Value:T120 Unit:T121
T119	Eq-Operator 839 840	≥
A31	Eq-Operator-Value T119 GTEQ
T120	Eq-Value 840 841	3
T121	Eq-Unit 852 873	upper limit of normal
A32	Eq-Unit-Value T121 ref-range-normal
T122	Observation 879 888	potassium
E54	Observation:T122 Name:T123 Eq-Comparison:E55
T123	Observation-Name 879 888	potassium
A33	Observation-Type-Value T123 lab
T124	Eq-Comparison 896 907	>5.5 mmol/L
E55	Eq-Comparison:T124 Operator:T125 Value:T126 Unit:T127 Per:T128
T125	Eq-Operator 896 897	>
A34	Eq-Operator-Value T125 GT
T126	Eq-Value 897 900	5.5
T127	Eq-Unit 901 905	mmol
T128	Eq-Unit 906 907	L
T129	Study 962 967	study
E56	Study:T129 Stability:T130
T130	Stability 936 942	affect
A35	Stability-Value T130 change
T131	Assertion 930 935	could
E57	Assertion:T131 Asserted:T130
A36	Assertion-Type-Value E57 hypothetical
T132	Condition 916 924	diseases
E58	Condition:T132 Name:T133
T133	Condition-Name 916 924	diseases
T134	Or 909 911	or
E59	Or:T134 Arg:E54 Arg2:E58
R5	Caused-By Arg1:T130 Arg2:E58	
